How Ozempic Is Reshaping Clothing Sizes

TODAY’S STORY

GLP-1 drugs like Ozempic are upending apparel inventory planning.

As the percentage of U.S. adults using these drugs grows—from 6% today to a projected 13% by 2030—retail brands are seeing increased demand for smaller sizes, with S and M selling out quickly.

Last June, Lululemon’s CEO mentioned the brand was “out of stock in some of [its] smaller sizes.” Impact Analytics also found a surge in demand for smaller sizes (XXS, XS, and S) in New York, where GLP-1 usage is particularly high.

Traditionally, many apparel brands used a 1-2-2-1 ordering model, stocking one part S, two parts M, two parts L, and one part XL. However, as body weight trends shift in the U.S., retailers are adopting a 2-2-1-1 model and revising their sizing strategies every six months instead of annually.

Updating sizing algorithms is costly but crucial for sales. As of November 2023, many retailers had a “size match percentage” of 20%-51%, well below the industry’s best-in-class 70% benchmark.

OUR PICKS

Here are today’s recs to help you live a smarter life…

1. Exercise & Feel Great — Anywhere!

This under-the-desk elliptical machine helps stimulate blood circulation, strengthen lower body muscles, and enhance joint flexibility. 32% off for a limited time.*

2. Precision Typing.

An instantly familiar experience, type quickly and comfortably on this full-size wireless keyboard, featuring reduced noise, palm rest, spill-resistant design, and adjustable tilt legs.*

3. See More.

Get 66% more vertical coverage with the latest version of Ring’s best-selling Video Doorbell (2nd Gen), now featuring Head-to-Toe Video.*

#SHORTS

These retailers could file for bankruptcy in 2025

@boringbusinesskieran

These retailers could file for bankruptcy in 2025 🛍️ #business #retail #bankruptcy

Watch on: TikTok, YouTube, Instagram

PREVIOUS STORIES

• KPMG blurs the lines between accounting and law — The accounting firm is trying to get a more significant piece of the law marketplace.

• Target shortens its go-to-market strategy — Faster trend cycles have given rise to a persistent demand for newness.

• New GLP-1 consumption patterns — Retailers across food and nonfood categories must adapt their strategies to meet shifting demand caused by spending changes from GLP-1 users.

• Sellers branch out beyond Amazon — 2024 was the year sellers became less loyal to Amazon.

• Non-Obvious Winners from the Ozempic Craze — Analysts predict Ozempic and other weight loss drugs will have ripples across many industries.

To read the web version of previous stories, click here.

If you have any comments or feedback, just respond to this email.

Thanks for reading,
Kieran & Justin Ryan